|
Re: Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease
|
8
|
Resverlogix Corp.
|
Aug 23, 2022 09:06AM
|
|
Re: Dr. Wong retires - Dr. Kulikowski in as CSO
|
9
|
Resverlogix Corp.
|
Aug 17, 2022 12:27AM
|
|
Re: Covid
|
4
|
Resverlogix Corp.
|
Aug 12, 2022 05:55PM
|
|
Re: Hepalink
|
1
|
Resverlogix Corp.
|
Jun 13, 2022 01:50PM
|
|
Re: Hepalink
|
4
|
Resverlogix Corp.
|
Jun 13, 2022 12:57PM
|
|
Re: AGM attendance
|
4
|
Resverlogix Corp.
|
May 24, 2022 08:37PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
1
|
Resverlogix Corp.
|
May 14, 2022 08:28PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
5
|
Resverlogix Corp.
|
May 14, 2022 07:48PM
|
|
Re: BTD
|
13
|
Resverlogix Corp.
|
Apr 24, 2022 09:25AM
|
|
Re: So I was able to finally set up a one on one meeting with...
|
4
|
Resverlogix Corp.
|
Mar 16, 2022 09:56AM
|
|
Re: https://themarkether...
|
4
|
Resverlogix Corp.
|
Mar 01, 2022 09:49PM
|
|
Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
|
8
|
Resverlogix Corp.
|
Jan 18, 2022 08:33AM
|
|
Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
|
5
|
Resverlogix Corp.
|
Jan 18, 2022 08:06AM
|
|
Pfizer Paxlovid
|
3
|
Resverlogix Corp.
|
Dec 22, 2021 01:53PM
|
|
Re: Momentum Players and Agoracom.com’s Rules
|
3
|
Resverlogix Corp.
|
Dec 18, 2021 11:23PM
|
|
Re: Risk vs Reward moving forward!
|
3
|
Resverlogix Corp.
|
Dec 18, 2021 08:00AM
|
|
Re: Risk vs Reward moving forward!
|
12
|
Resverlogix Corp.
|
Dec 17, 2021 09:28PM
|
|
Re: Question for posters
|
3
|
Resverlogix Corp.
|
Dec 09, 2021 05:47PM
|
|
Re: What are we waiting on?
|
11
|
Resverlogix Corp.
|
Dec 01, 2021 11:47AM
|
|
New Pfizer Antiviral Drug
|
3
|
Resverlogix Corp.
|
Nov 05, 2021 07:01AM
|
